3648 results for «2608»
3648 results
Coronary innovations and artificial intelligence: new devices, smarter tools, better outcomes
20 May 2026 – From EuroPCR 2026
This session provides a practical update on emerging coronary innovations and AI technologies, including next-generation calcium modification devices, bioresorbable scaffolds, sirolimus drug-coated balloons, and AI-driven coronary physiology and imaging tools. It offers a roadmap for integrating these advancements into clinical practice, addressing technology selection, reimbursement, training,...
Insight from recent evidence in structural heart disease: indications for LAA closure (CHAMPION) and PCI in TAVI candidates (PRO-TAVI)
20 May 2026 – From EuroPCR 2026
This session reviews recent evidence impacting the management of structural heart disease, focusing on left atrial appendage (LAA) closure indications and PCI considerations in transcatheter aortic valve implantation (TAVI) candidates. It discusses optimal strategies for coronary artery disease in TAVI patients and evaluates findings from the...
Tricuspid interventions: find the best candidate
20 May 2026 – From EuroPCR 2026
This session reviews the phenotypes of tricuspid regurgitation and their diagnostic pathways, emphasizing standardized and pragmatic diagnostic steps. It also addresses criteria for identifying optimal timing and candidates for tricuspid valve interventions.
Rescue techniques for coronary interventions
20 May 2026 – From EuroPCR 2026
This session presents an array of advanced rescue techniques employed in coronary interventions when unexpected complications arise. It features real-world cases including management of complex coronary artery aneurysms, malignant pericardial tamponade, challenging primary PCI scenarios, and innovative bailout strategies such as self-made covered stents and guidewire...
New TAVI platforms - Novel devices, early data
20 May 2026 – From EuroPCR 2026
Explore the latest developments in TAVI technology, featuring novel valve platforms and early clinical data. The session covers outcomes from new self-expandable and balloon-expandable valves, innovative single-operator techniques, redo TAVI approaches, and advances in CT sizing powered by deep learning.
Back to the future - Lessons from the past that can guide contemporary practice
20 May 2026 – From EuroPCR 2026
Reflecting on historical perspectives in the management of atherosclerotic coronary vascular disease, this session imparts valuable lessons to guide contemporary PCI practice. It emphasizes best practices in vessel preparation, evaluates the significance of drug-eluting stents, and provides a pathologist’s insight into mechanisms of PCI failure to...
Imaging the calcified lesions: what you need to see
20 May 2026 – From EuroPCR 2026
This session emphasizes critical imaging aspects necessary for assessing calcified coronary lesions. It addresses lesion-specific Agatston scoring, OCT-guided PCI optimization, coronary CT planning, histopathological insights, and predictors of stent underexpansion after calcium modification.
A critical appraisal of the recent evidence in the LAA closure field
20 May 2026 – From EuroPCR 2026
This session critically appraises recent evidence in the left atrial appendage (LAA) closure field, focusing on landmark trials such as CHAMPION-AF and CLOSURE AF. It discusses how these findings may influence patient selection and clinical practice, offering guidance on integrating new evidence into decision-making for stroke...
Major Late-Breaking Trials from EuroPCR 2026
20 May 2026 – From EuroPCR 2026
This session presents major late-breaking trials from EuroPCR 2026, reviewing contemporary evidence on coronary revascularization in TAVI patients, long-term outcomes of PCI versus CABG for left main disease, and comparative effectiveness of LAA closure versus NOAC in atrial fibrillation across age groups, with clinical practice implications.
Rethinking coronary artery disease: from ischaemia to atheroma - Implications of the Lancet Commission for Interventional Cardiology
20 May 2026 – From EuroPCR 2026
This session invites a re-evaluation of coronary artery disease by shifting focus from ischemia to atheroma, integrating insights from the Lancet Commission for Interventional Cardiology. It explores the significance of plaque burden, biology, and inflammation in guiding PCI decisions and outlines the future role of PCI...
Management of calcified lesions in challenging scenarios
20 May 2026 – From EuroPCR 2026
This session presents complex cases involving calcified coronary lesions in challenging clinical scenarios including STEMI, bifurcation lesions, tortuosity, and concurrent TAVI procedures. It demonstrates integrative strategies such as rota-lithotripsy and addresses decision-making processes in managing calcification beyond the coronaries to optimize patient outcomes.
TAVI: new approach
20 May 2026 – From EuroPCR 2026
This session introduces new frontiers in transcatheter aortic valve implantation (TAVI), including artificial intelligence-enabled systems and minimalist, radiation-free approaches guided by echocardiography. It covers complex procedural techniques such as axillary access under TEE guidance, precision snaring, and managing challenging anatomies, emphasizing advancements in safety and efficacy...
Optimal timing of aspirin discontinuation: when early is too early?
20 May 2026 – From EuroPCR 2026
This session critically evaluates the optimal timing for aspirin discontinuation after PCI, discussing outcomes of aspirin-free strategies initiated within one month versus three months post-procedure. It considers differential effects of DAPT duration based on ACS presentation and bleeding risk, supported by meta-analyses and real-world data to...
Bifurcation PCI with complications - Part 1
20 May 2026 – From EuroPCR 2026
This session addresses complications encountered during bifurcation PCI through real-world cases involving stent dislodgement, entrapped guidewires, failed wiring techniques, and fractured devices. It highlights technical rescue maneuvers, the role of intravascular imaging, and long-term challenges encountered in managing complex bifurcation lesions to improve procedural success and...
New devices for structural interventions
20 May 2026 – From EuroPCR 2026
Explore the latest advancements in structural interventions with a focus on novel devices and their early clinical outcomes. This session reviews cutting-edge technologies including balloon-expandable TAVI, percutaneous mechanical aspiration for infective endocarditis, and emerging transcatheter tricuspid valve replacement systems, alongside multicenter evaluations of TEER devices in...
The digital pulse: innovation in the cathlab
20 May 2026 – From EuroPCR 2026
This session highlights transformative innovations in the catheterization laboratory that prioritize patient-centered care and enhanced safety. Focus areas include advancements in radiation practice through new technology and the integration of artificial intelligence to improve image analysis, decision-making, and procedural efficiency in interventional cardiology.
Complex transfemoral TAVI: how to manage the root to success
20 May 2026 – From EuroPCR 2026
Addressing the challenges of complex transfemoral TAVI, this session provides expert guidance on managing difficult vascular access routes to ensure procedural success. Topics include advanced techniques for straightening pathways, managing hostile access, and innovative strategies for contrast-zero TAVI in challenging anatomies.
New strategies in STEMI treatments
20 May 2026 – From EuroPCR 2026
Investigate new strategies in STEMI treatment through data from international registries and clinical trials. This session examines the comparative efficacy of sirolimus versus paclitaxel-coated balloons, plaque modification in calcified lesions, novel cardioprotective techniques during primary PCI, and the role of AI-assisted ECG interpretation in STEMI pathways.
Debate: how will AI change the cardiology landscape in the next five years?
20 May 2026 – From EuroPCR 2026
Delve into the anticipated impact of artificial intelligence on cardiology over the next five years. This session addresses AI's role in reporting, triage, workflow optimization, and decision-making, while distinguishing realistic clinical benefits from hype. It also discusses governance, accountability, and legal considerations surrounding AI adoption in...
Structural heart devices: what's new and how it reaches your cathlab
20 May 2026 – From EuroPCR 2026
Discover the latest innovations in structural heart devices, spanning new TAVR platforms, mitral and tricuspid valve technologies, leaflet modification, and closure devices. Gain insight into the comprehensive innovation pathway from concept and prototyping to regulatory approval and clinical adoption, with perspectives from physician-innovators on drivers of...